NFKB1 and COVID-19: Additionally, it has been reported that the SARS-CoV S protein can upregulate IL-6 and TNF-α expressions through the NF-κB signaling pathway, increasing the levels of inflammatory factors in COVID-19 patients, and causing serious lung damage [35,36].